You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Supplements Articles
Popular Supplements Articles
Highly Recommended Supplements Articles
Send a link to this page to your friends and colleagues.
A recent study conducted as part of the Heart Outcomes Prevention Evaluation (HOPE) trial found that vitamin E supplementation had no effect on cardiovascular disease, other coronary risk factors, or kidney disease in middle-aged and elderly people with diabetes.
The multinational study involved 3,654 subjects in the United States, Canada and Germany. All participants were older than 55 and had cardiovascular disease or diabetes with at least one additional coronary risk factor.
Each subject was randomly assigned to take 400 international units (IU) of vitamin E, 10 mg of the ACE inhibitor Altace (ramipril) or their respective placebos and followed for an average of 4.5 years.
The researchers found that a daily supplement of 400 IU of vitamin E had a "neutral effect" on the primary outcomes studied in the trial—heart attack, stroke or death resulting from cardiovascular disease—as well as on other outcomes measured, such as total mortality, hospitalizations for unstable angina or heart surgery and kidney disease.
—Diabetes Care, November 2002
0 comments - Jan 1, 2003
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.